Helmut Remschmidt ; Cornelio Banaag Jr. ; François Bange ; Manuel Bouvard ; F. Xavier Castellanos ; David Coghill ; Jesus Gomez-Plascencia ; Laurence Greenhill ; Michael Huss ; Luis Rohde ; Paramala Santosh ; Martin Schmidt ; Yee-Jin Shin ; Eric Taylor ; Kenneth Whiting
Citation
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, Vol.14(3) : 127-137, 2005
Adolescent ; Algorithms* ; Attention Deficit Disorder with Hyperactivity/diagnosis ; Attention Deficit Disorder with Hyperactivity/etiology ; Attention Deficit Disorder with Hyperactivity/therapy* ; Central Nervous System Stimulants/therapeutic use ; Child ; Consensus* ; Diagnosis, Differential ; Diagnostic and Statistical Manual of Mental Disorders ; Dose-Response Relationship, Drug ; Global Health* ; Humans ; Psychotherapy/methods
Keywords
consensus ; ADHD ; treatment
Abstract
A Global ADHD Working Group of experienced clinicians and researchers was gathered to review the latest evidence, discuss current best practice in the treatment of attention-deficit/hyperactivity disorder (ADHD), and make a statement based on consensus. The statement aims to re-affirm ADHD as a valid disorder that exists across different cultures, has a significant global impact, and should be diagnosed and effectively treated wherever it occurs.
ADHD is one of the most common neurobehavioural disorders of childhood and impacts on many aspects of development, including social, emotional and cognitive functioning, in the home and school environment. Although these findings are from developed countries, the impact in developing countries is likely to be similar.
There is strong supportive evidence for the validity of ADHD as a syndrome with neurobiological aspects, and complex genetic factors are primarily implicated in the aetiology. Accurate diagnosis and measurement of impairment is important to enable appropriate and successful management of symptoms. ADHD is a persistent condition that needs to be treated and monitored over time. The evidence supporting medication-based interventions (such as methylphenidate) is strong and consensus treatment algorithms to guide the multimodal treatment of ADHD, alone and in combination with common comorbidities, are suggested.